The Pink Pill: Sex, Drugs and Who Has Control (2026)
.jpg)
| Theatrical Performance | ||
| Domestic Box Office | n/a | |
| Further financial details... | ||
Synopsis
At its center is Cindy Eckert, entrepreneur and women’s health advocate, whose trademark pink and fearless determination made her a lightning rod in the battle to bring Addyi—which the media dubbed “female Viagra”—to market. Eckert confronted gender bias head-on, ultimately winning approval for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women in 2015. This past December, the FDA expanded its approval to include postmenopausal women under 65.
Metrics
Movie Details
| Video Release: | March 6th, 2026 by Paramount + |
| Source: | Based on Real Life Events |
| Genre: | Documentary |
| Production Method: | Live Action |
| Creative Type: | Factual |
| Production Countries: | Canada |
| Languages: | English |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.
Synopsis
At its center is Cindy Eckert, entrepreneur and women’s health advocate, whose trademark pink and fearless determination made her a lightning rod in the battle to bring Addyi—which the media dubbed “female Viagra”—to market. Eckert confronted gender bias head-on, ultimately winning approval for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women in 2015. This past December, the FDA expanded its approval to include postmenopausal women under 65.
Metrics
Movie Details
| Video Release: | March 6th, 2026 by Paramount + |
| Source: | Based on Real Life Events |
| Genre: | Documentary |
| Production Method: | Live Action |
| Creative Type: | Factual |
| Production Countries: | Canada |
| Languages: | English |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.